Introduction
Observational studies' 2 and mathematical models3 of human immunodeficiency virus (HIV) infected individuals in Africa suggest that progression from asymptomatic disease to acquired immune deficiency syndrome (AIDS) and death are faster than in developed countries. This may be due to poverty4 and malnutrition, limited access to medical care,5 a different spectrum of AIDS indicator illnesses (All),67 concurrent debilitating infections, different viral strains, or to a combination of these factors.
Africans who live in Europe and are found to be HIV antibody positive come from diverse countries and backgrounds. Whether or not their survival with HIV disease is more similar to that seen in the country of origin or country of residence has not been determined, but such information could provide epidemiological clues to factors influencing disease progression. We present here the analysis of a retrospectively constructed prevalent cohort of black Africans attending an HIV outpatient clinic in London to describe, progression to AIDS, risk factors for development of AIDS and survival following a diagnosis of AIDS. Comparisons are made with studies of the survival experience of HIV-infected individuals born in Europe and North America.
Subjects and methods
We attempted to include all patients from subSaharan Africa who had HIV infection diagnosed between January 1986 and October Decline in CD4 lymphocyte count was calculated by linear regression for each patient with more than three counts greater than 20 x 106/1 during the follow up period. A weighted mean rate of decline was then calculated. The probability of survival to clinical end points of AIDS and death was described using Kaplan- significantly (fig la) . Different survival distributions were also noted for patients aged above and below 30 years at baseline (log rank X2 6.37, p = 0-012) and (table 3) . Table 4 shows how survival of this patient cohort compares with that observed in other populations.
Discussion
This cohort of patients of sub-Saharan African origin, constructed retrospectively from clinic records, provides information on the risk of developing AIDS and survival following a diagnosis of AIDS. The date of HIV infection in these patients was not known. Estimates of survival time relate to the date at which HIV infection was diagnosed. Comparison with a control population from this centre was not made so we reviewed published studies to examine survival patterns of our cohort. In a large prevalent cohort of patients in the USA,9 enrolled at a similar stage of disease (defined by baseline CD4 count), the cumulative incidence of AII (31.5 to 38% after two years for subjects whose CD4 count was 200-299 x 106/1 at enrolment) was similar to that which occurred in our patients. Progression to an AIDS indicator illness was strongly related to presentation with more advanced disease. 
